BioCryst Pharmaceuticals shares owned by Ensign Peak Advisors
Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Ensign Peak Advisors
from 13F filings
Historical chart of Ensign Peak Advisors investment in BioCryst Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including BioCryst Pharmaceuticals held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in BioCryst Pharmaceuticals by Ensign Peak Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $672k | 88k | 7.60 |
2024-06-30 | $546k | 88k | 6.18 |
2024-03-31 | $449k | 88k | 5.08 |
2023-09-30 | $657k | 93k | 7.08 |
2023-06-30 | $654k | 93k | 7.04 |
2023-03-31 | $775k | 93k | 8.34 |
2022-12-31 | $936k | 82k | 11.48 |
2022-09-30 | $672k | 53k | 12.59 |
2022-06-30 | $548k | 52k | 10.57 |
2022-03-31 | $843k | 52k | 16.26 |
2021-12-31 | $718k | 52k | 13.85 |